Human Microbiome Research and Development for Overcoming Pediatric Diseases
Prediction and Treatment of Pediatric Diseases and Long-term Outcomes Through Microbiome and Multi-Omics Study by Life Cycle
Hanyang University
500 participants
Jan 1, 2022
OBSERVATIONAL
Conditions
Summary
Prediction and treatment of pediatric diseases and long-term outcomes through microbiome and multi-omics analysis by life cycle: We aim to demonstrate that a wide range of diseases are associated with gut microbiome dysbiosis and to investigate the subsequent recovery (restoration) or further deterioration of the gut microbiome over time. This study seeks to offer a novel perspective on changes in the gut microbiome, particularly in the context of the gut-lung and gut-brain axes.
Eligibility
Inclusion Criteria1
- children (including newborns) who have obtained their consent from their guardians
Exclusion Criteria1
- subjects who did not obtain consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06812091